Início › Câncer de Ovário › Rhode Island › Providence
Ensaios clínicos de Câncer de Ovário em Providence, RI
15 estudos para Câncer de Ovário estão buscando participantes em locais em Providence e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RecrutandoFase 2
- Women and Infants Hospital, Providence
- Roger Williams Medical Center, Providence
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
RecrutandoFase 1/2
- Research Site, Providence
TLR9 Immunotherapy for Peritoneal Carcinomatosis
RecrutandoFase 1
- Rhode Island and the Miriam Hospitals (Brown University Health), Providence
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
RecrutandoFase 2
- Women & Infants Hospital /ID# 277930, Providence
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
RecrutandoFase 2
- Women & Infants Hospital /ID# 274716, Providence
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
RecrutandoFase 3
- Women & Infants Hospital, Providence
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
RecrutandoFase 3
- Women & Infants Hospital ( Site 0001), Providence
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
RecrutandoFase 3
- Women & Infants Hospital ( Site 0050), Providence
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Recrutando
- Women and Infants Hospital, Providence
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
RecrutandoFase 3
- Women and Infants Hospital, Providence
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
RecrutandoFase 1/2
- Women and Infants Hospital of Rhode Island, Providence
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
RecrutandoFase 2
- Lifespan Cancer Institute - Rhode Island Hospital, Providence
Use of CA125 and Complementary Biomarkers for the Early Detection of Ovarian Cancer in Low Risk Women
RecrutandoVoluntários saudáveis bem-vindos
- Women's and Infant's Hospital, Providence
A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer
RecrutandoFase 1
- Site 0191, Providence
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecrutandoEstudo observacional
- Massive Bio SYNERGY-AI site, Providence
Ensaios de Câncer de Ovário em outras cidades
- Houston, TX89 estudos
- New York City, NY69 estudos
- Boston, MA61 estudos
- Los Angeles, CA50 estudos
- Nashville, TN49 estudos
- Arlington, VA46 estudos
- Philadelphia, PA44 estudos
- Columbus, OH39 estudos
- St. Louis, MO38 estudos
- Chicago, IL36 estudos
- San Antonio, TX31 estudos
- Cleveland, OH30 estudos
Outros estudos em Providence
- Câncer Endometrial14 estudos
- Obesidade14 estudos
- Câncer de Pulmão de Não Pequenas Células12 estudos
- Câncer (todos os tipos)12 estudos
- Doença de Crohn12 estudos
- Câncer de Mama11 estudos
- Colite ulcerativa11 estudos
- Leucemia Mieloide Aguda10 estudos
- Câncer Metastático9 estudos
- Sobrepeso9 estudos
- Transtorno por Uso de Álcool (AUD)8 estudos
- Doença de Alzheimer8 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.